Verisante Technology Inc., a medical device company, engages in commercializing skin cancer detection systems. The company's products comprise Verisante Aura, which helps in the detection of various forms of skin cancer, including basal cell and squamous cell carcinoma, and melanoma; and Verisante Core for the detection of lung, cervical, gastrointestinal, and colo-rectal cancers. It also owns all the rights to the ClearVu and ClearVu Elite endoscopy systems for the detection of lung cancer. Verisante Technology has a licensing agreement with the BC Cancer Agency for the manufacture, distribution, and sale of products based on patented skin cancer detection technology. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. Verisante Technology Inc. was founded in 2006 and is based in Richmond, Canada.
Industry, Sector and Symbol
Industry Health services
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone604-605-0507
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$20,000.00
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Verisante Technology (OTCMKTS:VRSEF) Frequently Asked Questions
What is Verisante Technology's stock symbol?
Verisante Technology trades on the OTCMKTS under the ticker symbol "VRSEF."
Has Verisante Technology been receiving favorable news coverage?
News articles about VRSEF stock have trended somewhat negative on Wednesday, according to InfoTrie. The research group ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Verisante Technology earned a media sentiment score of -1.6 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for Verisante Technology.
Who are some of Verisante Technology's key competitors?
Some companies that are related to Verisante Technology include 1933 Industries (TGIF), 21st North (ULGX), Abacus Health Products (ABAHF), Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Acreage (ACRGF), Actelion (ALIOF), AEGON (AGN), Aeolus Pharmaceuticals (AOLS), Affymax (AFFY), Alchemist Mining (AMS), ALGAE TEC LTD/S (ALGXY), Alliance Growers (ACG) and Almirall (LBTSF).
Who are Verisante Technology's key executives?
Verisante Technology's management team includes the folowing people:
- Mr. Thomas A. Braun BA, J.D., LLM, Pres, CEO & Director (Age 51)
- Mr. Zi Cheng Xu, CFO & Director
- Mr. Rizah Bahic, Exec. Officer
How do I buy shares of Verisante Technology?
Shares of VRSEF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Verisante Technology's stock price today?
One share of VRSEF stock can currently be purchased for approximately $0.00.
What is Verisante Technology's official website?
How can I contact Verisante Technology?
Verisante Technology's mailing address is 2639 Viking Way Suite 140, Richmond A1, V6V 3B7. The company can be reached via phone at 604-605-0507.
MarketBeat Community Rating for Verisante Technology (OTCMKTS VRSEF)
MarketBeat's community ratings are surveys of what our community members think about Verisante Technology and other stocks. Vote "Outperform" if you believe VRSEF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VRSEF will underperform the S&P 500 over the long term. You may vote once every thirty days.
